Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
Source link
Trending
- Elon Musk says xAI expects to keep buying GPUs from Nvidia and AMD
- Target’s earnings report will show tariff pressure, Wall Street says
- What the U.S. credit downgrade means for tax-free income investors
- Warby Parker pops 15% on $150 million Google smart glasses partnership
- NFL Commissioner Roger Goodell could double international games
- Spotify is gearing up for a move to fresh record highs, according to the charts
- S&P 500’s win streak may end — but, our newest stock gets a double-dose of good news
- Habeas corpus gives Trump right ‘to remove people’
Novo Nordisk's future in doubt after Wegovy maker's 'surprise' CEO ouster
